<DOC>
	<DOCNO>NCT02967341</DOCNO>
	<brief_summary>To validate blood draw via central venous catheter ( Port A Cath Â® ) pharmacokinetic study ciprofloxacin patient treatment childhood cancer .</brief_summary>
	<brief_title>Blood Draw Validation Ciprofloxacin Pharmacokinetic Research Pediatric Cancer Patients</brief_title>
	<detailed_description>The concentration cipro determine use validate high-performance liquid chromatographic ( HPLC ) method fluorescence detection . Unbound concentration determine adjust pH plasma sample physiological pH ( 7.4 ) CO2 incubator , follow ultrafiltration extraction ciprofloxacin ultrafiltrate ( describe ) prior injection onto HPLC system .</detailed_description>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<criteria>Children 1 month 18 year age treatment type childhood cancer use ciprofloxacin prophylaxis febrile neutropenia part regular treatment PAC intravenous medication blood draw . Children exclude study unable obtain informed consent parent assent child ( he/she 12 year age ) aspire blood PAC .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>